Nityam Dipakam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 12 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 4.98%
(FY 2022)
- Profit 77.56%
(FY 2022)
- Ebitda -90.79%
(FY 2022)
- Net Worth 5.59%
(FY 2022)
- Total Assets -6.59%
(FY 2022)
About Nityam Dipakam Pharmaceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dilip Gune, Vanita Gune, Manoj Gune, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233PN2012PTC145559
- Company No.
145559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nityam Dipakam Pharmaceuticals Private Limited offer?
Nityam Dipakam Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Organic Soap, Bath Soaps, Herbal Skin Care Cosmetics, Herbal Soaps, Ayurvedic Soap.
Who are the key members and board of directors at Nityam Dipakam Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Kowjalgi  | Director | 29-Nov-2012 | Current |
| Manoj Gune | Director | 29-Nov-2012 | Current |
| Dilip Gune | Director | 29-Nov-2012 | Current |
| Vanita Gune | Director | 29-Nov-2012 | Current |
| Madhura Gune | Director | 29-Nov-2012 | Current |
| Ketaki Kowjalgi | Director | 29-Nov-2012 | Current |
Financial Performance of Nityam Dipakam Pharmaceuticals.
Nityam Dipakam Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.98% increase. The company also saw a substantial improvement in profitability, with a 77.56% increase in profit. The company's net worth moved up by a moderate rise of 5.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nityam Dipakam Pharmaceuticals?
In 2019, Nityam Dipakam Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S.G. Phyto Pharma Private LimitedActive 24 years 1 monthDilip Gune, Vanita Gune and 1 more are mutual person
Raj Vaidya Gunes Shahu Aryoushadi Karkhana LtdActive 82 years 3 monthsDilip Gune and Manoj Gune are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nityam Dipakam Pharmaceuticals?
Unlock and access historical data on people associated with Nityam Dipakam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nityam Dipakam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nityam Dipakam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
